Your browser is no longer supported. Please, upgrade your browser.
Settings
LLY Eli Lilly and Company daily Stock Chart
LLY [NYSE]
Eli Lilly and Company
IndexS&P 500 P/E43.08 EPS (ttm)2.71 Insider Own12.20% Shs Outstand971.00M Perf Week0.67%
Market Cap113.40B Forward P/E17.68 EPS next Y6.61 Insider Trans-1.40% Shs Float968.85M Perf Month-1.22%
Income2.75B PEG4.01 EPS next Q1.44 Inst Own83.20% Short Float1.72% Perf Quarter-5.73%
Sales23.95B P/S4.74 EPS this Y102.80% Inst Trans-4.78% Short Ratio1.10 Perf Half Y1.80%
Book/sh2.53 P/B46.16 EPS next Y16.67% ROA14.80% Target Price124.57 Perf Year41.26%
Cash/sh2.20 P/C53.06 EPS next 5Y10.74% ROE67.70% 52W Range81.65 - 132.13 Perf YTD0.92%
Dividend2.58 P/FCF60.98 EPS past 5Y-5.30% ROI14.70% 52W High-11.61% Beta0.26
Dividend %2.21% Quick Ratio0.80 Sales past 5Y1.20% Gross Margin75.00% 52W Low43.04% ATR2.01
Employees38680 Current Ratio1.10 Sales Q/Q2.60% Oper. Margin12.50% RSI (14)44.24 Volatility1.28% 1.47%
OptionableYes Debt/Eq6.44 EPS Q/Q-48.70% Profit Margin26.10% Rel Volume0.14 Prev Close116.81
ShortableYes LT Debt/Eq5.49 EarningsApr 30 BMO Payout36.90% Avg Volume15.09M Price116.79
Recom2.50 SMA200.03% SMA50-3.95% SMA2001.56% Volume2,084,187 Change-0.02%
Apr-24-19Upgrade Edward Jones Hold → Buy
Apr-11-19Downgrade Guggenheim Buy → Neutral
Mar-12-19Initiated JP Morgan Overweight $140
Jan-23-19Initiated UBS Buy $131
Nov-26-18Downgrade Citigroup Buy → Neutral
Oct-31-18Upgrade Credit Suisse Underperform → Neutral
Oct-09-18Initiated Guggenheim Buy
Oct-01-18Reiterated SunTrust Buy $105 → $123
Sep-26-18Resumed JP Morgan Overweight $117
Jul-25-18Downgrade Berenberg Buy → Hold
Jun-08-18Initiated Cantor Fitzgerald Overweight $100
Apr-13-18Upgrade BMO Capital Markets Underperform → Market Perform $74 → $79
Jan-22-18Downgrade Credit Suisse Neutral → Underperform
Jan-16-18Downgrade Goldman Buy → Neutral
Jan-05-18Upgrade Argus Hold → Buy
Oct-10-17Downgrade Credit Suisse Outperform → Neutral
Jul-26-17Downgrade Leerink Partners Outperform → Mkt Perform
Apr-27-17Downgrade Argus Buy → Hold
Apr-17-17Downgrade Morgan Stanley Overweight → Equal-Weight
Apr-07-17Reiterated Barclays Overweight $85 → $90
May-24-19 09:56AM  Nektar (NKTR) Announces Formation of CNS-Focused Subsidiary Zacks
09:30AM  Pharma Stock Roundup: MRK's Cancer Biotech Buyout, ABBV, LLY's Pipeline Updates Zacks
May-23-19 03:53PM  Earnings Preview: Veeva (VEEV), Palo Alto Networks (PANW), Workday (WDAY) Zacks
10:38AM  Amgen (AMGN) Offers to Acquire Drug Discovery Platform Zacks
09:08AM  Lilly (LLY) Launches Half-Priced Version of Humalog Insulin Zacks
08:20AM  J&J's Invokana sNDA Gets Priority Review Status From FDA Zacks
May-22-19 05:13PM  Array BioPharma Gains on Colorectal Cancer Study Success Zacks
04:30PM  3 Tech Stocks for Growth Investors to Buy Right Now Zacks
02:31PM  Eli Lilly says lower-priced insulin is now available Yahoo Finance Video
11:26AM  Should We Worry About Eli Lilly and Company's (NYSE:LLY) P/E Ratio? Simply Wall St.
09:50AM  Lilly's Crohn's Disease Candidate Meets Phase II Study Goals Zacks
09:37AM  Merck to Buy Private Cancer Drugmaker Peloton Therapeutics Zacks
06:53AM  Eli Lilly's Insulin Lispro Injection available at half the list price of Humalog MarketWatch
06:46AM  Lilly selling half-price version of popular Humalog insulin Associated Press
06:30AM  Lilly's Lower-Priced Insulin Now Available PR Newswire
May-21-19 04:16PM  Why This Biotech Stock Succeeded In Colon Cancer As Others Struggled Investor's Business Daily
01:15PM  Lilly's Mirikizumab Met Primary Endpoint and Key Secondary Endpoints in Phase 2 Study, Including Reductions of Gastrointestinal Lesions PR Newswire
08:13AM  Merck agrees $1bn deal to buy biopharmaceutical company Peloton Financial Times
May-20-19 12:04PM  Credit Suisse Absolutely Is Right to Double Down on Pfizer Stock InvestorPlace
09:15AM  Why Eli Lilly (LLY) is a Top Dividend Stock for Your Portfolio Zacks
May-19-19 09:00AM  Better Buy: Eli Lilly vs. Pfizer Motley Fool
May-18-19 09:50AM  The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trial Readouts And IPOs Benzinga
May-17-19 08:35AM  Pharma Stock Roundup: FDA Okays Line Extensions of LLY, PFE, ABBV Cancer Drugs Zacks
May-16-19 04:30PM  Lilly to Participate in UBS Global Healthcare Conference PR Newswire
08:20AM  Pfizer's Eczema Candidate Meets All Goals in Phase III Study Zacks
May-15-19 05:00PM  Data Presentations at ASCO 2019 Highlight Lilly's Targeted Approach to Developing Treatments for Patients Living with Cancer PR Newswire
10:16AM  3 Stocks With Big News Coming at ASCO 2019 Motley Fool
09:12AM  The Zacks Analyst Blog Highlights: Alphabet, Eli Lilly, CVS, Marriott and TELUS Zacks
09:07AM  3 Top Diabetes Stocks to Watch in May Motley Fool
06:30AM  Lilly to Participate in Bank of America Merrill Lynch Health Care Conference PR Newswire
May-14-19 02:41PM  Top Research Reports for Alphabet, Eli Lilly & CVS Health Zacks
09:46AM  Lilly's Cyramza Gets FDA Nod for Second-Line Liver Cancer Zacks
May-13-19 06:45AM  Lilly's CYRAMZA® (ramucirumab) Becomes First FDA-Approved Biomarker-Driven Therapy in Patients with Hepatocellular Carcinoma PR Newswire
May-10-19 03:50PM  Lilly's new migraine drug pulls ahead of Amgen in fierce battle for new prescriptions Reuters
03:10PM  Lilly's new migraine drug pulls ahead of Amgen in fierce battle for new prescriptions Reuters
May-09-19 03:30PM  Radius (RDUS) Posts Narrower Q1 Loss, Misses on Revenues Zacks
01:28PM  Why this former health care CEO thinks this Uber board member is crucial to its success Yahoo Finance Video
May-08-19 07:44PM  TV pitches for prescription drugs will have to include price Associated Press
06:45AM  AAN 2019: Two New Analyses of Lasmiditan Phase 3 Studies Measured Onset of Effect and the Effect of Lasmiditan in Patients with Prior Triptan Experience PR Newswire
May-07-19 09:27AM  Allergan (AGN) Beats on Q1 Earnings & Sales, Raises '19 View Zacks
May-06-19 02:16PM  Lilly Declares Second-Quarter 2019 Dividend PR Newswire
01:32PM  Which Pharmaceutical Stocks Are Outperforming All Other Stocks? Investor's Business Daily
06:45AM  AAN 2019: Pooled Analyses of Two Emgality® (galcanezumab-gnlm) Phase 3 Studies Show Reduction in Monthly Migraine Headache Days in Low- and High-Frequency Episodic Migraine Subgroups PR Newswire
02:57AM  Edited Transcript of LLY earnings conference call or presentation 30-Apr-19 1:00pm GMT Thomson Reuters StreetEvents
May-03-19 03:18PM  Migraine drugs cause pain for investors CNBC Videos
02:38PM  Flippin Bruce & Porter Inc Buys Norfolk Southern Corp, Sells Eli Lilly and Co GuruFocus.com
11:37AM  Novo Nordisk (NVO) Q1 Earnings and Revenues Miss Estimates Zacks
06:28AM  Teva (TEVA) Q1 Earnings Beat, Copaxone Drags Sales Down Zacks
06:10AM  Pharma Stock Roundup: MRK, LLY, PFE Report Q1 Earnings, SNY, ABBV Drugs Get EU Nod Zacks
May-02-19 01:44PM  Teva's new migraine drug helps to contain profit fall Reuters
09:26AM  United Therapeutics (UTHR) Down Despite Q1 Earnings Beat Zacks
06:45AM  Lilly to Present New Data at AAN 2019 on Emgality® (galcanezumab-gnlm) and Lasmiditan Reinforcing Breadth of Headache Disorders Portfolio PR Newswire
May-01-19 06:56PM  The Top Pharma Stocks for 2019 Investopedia
09:15AM  Are You Looking for a High-Growth Dividend Stock? Eli Lilly (LLY) Could Be a Great Choice Zacks
09:05AM  Amgen (AMGN) Q1 Earnings Top, Sales Hurt by Pricing Pressure Zacks
07:29AM  Eli Lilly misses on revenue in face of pricing pressures and growing generic competition MarketWatch
Apr-30-19 11:27PM  Eli Lilly and Company (LLY) Q1 2019 Earnings Call Transcript Motley Fool
04:44PM  Eli Lilly misses estimates for top-selling diabetes drug Trulicity, shares slip Reuters
04:23PM  Alphabet and Eli Lilly tumble while WageWorks and GE jump Associated Press
04:22PM  S&P 500 ekes out third straight record close; Nasdaq retreats after Google revenue miss MarketWatch
04:11PM  Dow Drug Giants Top First-Quarter Estimates; But Another Pharma Dives Investor's Business Daily
03:00PM  What's Behind Eli Lilly's Mixed Q1 Results Motley Fool
12:46PM  3 Tech Stocks for Growth Investors to Buy Right Now Zacks
12:11PM  Eli Lilly misses estimates for top-selling diabetes drug Trulicity, shares slip Reuters
11:31AM  Lilly (LLY) Down Despite Q1 Earnings Beat on Sales View Cut Zacks
10:46AM  Big Pharma Puts the Price Squeeze on Itself Bloomberg
10:10AM  Incyte (INCY) Q1 Earnings & Revenues Beat Estimates, Up Y/Y Zacks
09:52AM  Fed and tech stocks could crack the market rally, warns Wall Street strategist MarketWatch
09:32AM  Eli Lilly misses estimates for top-selling diabetes drug Trulicity, shares slip Reuters
08:37AM  Stocks making the biggest moves premarket: Alphabet, General Electric, MGM Resorts & more CNBC
07:27AM  Eli Lilly Reports Better-Than-Expected Earnings but Shares Decline TheStreet.com
07:20AM  Three major pharmaceutical companies just reported earnings here's how they did CNBC
07:16AM  Here's a breakdown of Big Pharma earnings from Merck, Pfizer, Eli Lilly CNBC Videos
07:07AM  Pricing pressure weighs on revenue at drugmaker Eli Lilly Financial Times
06:59AM  Eli Lilly's stock sinks after earnings beat but revenue comes up short, hurt by Trulicity and Alimta misses MarketWatch
06:41AM  Lilly: 1Q Earnings Snapshot Associated Press
06:25AM  Lilly Reports Solid First-Quarter 2019 Financial Results, Updates 2019 Guidance to Reflect Disposition of Elanco Animal Health PR Newswire
05:32AM  Today Is Earnings Day for Big Pharma. Heres What to Watch. Barrons.com
02:28AM  Eli Lilly Earnings Beat, Revenue Misses In Q1 Investing.com
Apr-29-19 04:45PM  Insulin-maker Eli Lilly is scheduled to report earnings Tuesday. Heres what to expect MarketWatch
01:42PM  Beaten-down health-care companies join Apple and Google in earnings parade MarketWatch
12:23PM  The obscure advisory committees at the heart of the U.S. drug pricing debate Reuters
11:05AM  The obscure advisory committees at the heart of the U.S. drug pricing debate Reuters
08:45AM  Looking for a Growth Stock? 3 Reasons Why Lilly (LLY) is a Solid Choice Zacks
Apr-26-19 11:28AM  U.S. Court of Appeals Rules in Favor of Lilly in Alimta Vitamin Regimen Patent Lawsuit PR Newswire
10:59AM  AstraZeneca's (AZN) Q1 Earnings Beat, New Drugs Drive Sales Zacks
09:29AM  Sanofi (SNY) Q1 Earnings Top, Genzyme & Vaccines Drive Sales Zacks
Apr-25-19 09:55AM  Bayer (BAYRY) Q1 Earnings Beat Estimates, Revenues Up Y/Y Zacks
07:19AM  Eli Lilly's Lartruvo is being pulled from the market, but patients who are already taking the drug will still have access under new program MarketWatch
06:45AM  Lilly to Establish an Access Program for Patients as it Prepares to Withdraw Lartruvo from the Global Market PR Newswire
Apr-24-19 04:25PM  Eli Lilly (LLY) to Report Q1 Earnings: What's in the Cards? Zacks
Apr-23-19 11:10AM  The best companies for employees in 2019 Yahoo Finance Video
10:33AM  Teva stops testing its migraine drug as cluster headache treatment Reuters
08:08AM  The Daily Biotech Pulse: FDA Accepts Alder's Migraine Drug Application, Gritstone Offering, Lilly's Chinese Sale Benzinga
Apr-22-19 10:05PM  Lilly Announces Sale of Legacy Antibiotics Brands and Manufacturing Facility in China PR Newswire
05:50PM  The best companies for employees in 2019 Yahoo Finance
11:13AM  Eli Lilly Falls Despite Positive Phase 3 Results From Taltz Study TheStreet.com
11:12AM  Update: Eli Lilly (NYSE:LLY) Stock Gained 97% In The Last Five Years Simply Wall St.
10:24AM  Eli Lilly-Pfizer's Non-Opioid Painkiller Faces Safety, Efficacy Concerns Benzinga
08:00AM  Eli Lilly stock down 3.4% despite positive Phase 3 findings for Taltz MarketWatch
Eli Lilly and Company discovers, develops, manufactures, and markets pharmaceutical products worldwide. The company operates in two segments, Human Pharmaceutical Products and Animal Health Products. It offers endocrinology products for the treatment of diabetes; osteoporosis in postmenopausal women and men; and human growth hormone deficiency and pediatric growth conditions. The company also provides neuroscience products for the treatment of depressive disorder, diabetic peripheral neuropathic pain, anxiety disorder, fibromyalgia, and chronic musculoskeletal pain; schizophrenia; attention-deficit hyperactivity disorder; obsessive-compulsive disorder, bulimia nervosa, and panic disorder; and positron emission tomography imaging of beta-amyloid neurotic plaques in adult brains, as well as migraine prevention. In addition, it offers immunology products for the treatment of rheumatoid arthritis and plaque psoriasis; oncology products to treat non-small cell lung, colorectal, head and neck, pancreatic, metastatic breast, ovarian, bladder, and metastatic gastric cancers, as well as malignant pleural mesothelioma; and cardiovascular products to treat erectile dysfunction and benign prostatic hyperplasia, and acute coronary syndrome. Further, the company provides animal health products, such as cattle feed additives; leanness and performance enhancers for swine and cattle; antibiotics to treat respiratory and enteric diseases in swine and poultry; anticoccidial agents for poultry use; and chewable tablets that kill fleas and prevent heartworm diseases. Additionally, it offers vaccines to prevent bordetella, Lyme disease, rabies, and parvovirus. The company has collaboration agreements with Daiichi Sankyo Co., Ltd.; Incyte Corporation; Pfizer Inc.; AstraZeneca; Nektar Therapeutics; NextCure, Inc.; Dicerna Pharmaceuticals; AC Immune SA; and Avidity Biosciences, Inc. Eli Lilly and Company was founded in 1876 and is headquartered in Indianapolis, Indiana.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Shaw ChristiSVP and Pres., Lilly Bio-MedsMay 03Sale117.147,577887,5700May 07 02:18 PM
Shaw ChristiSVP and Pres., Lilly Bio-MedsMay 01Option Exercise0.0013,750013,750May 03 04:04 PM
Zulueta Alfonso GSVP & President, Lilly Int'lApr 12Sale124.6510,0001,246,50057,806Apr 16 02:48 PM
Barnes Melissa SChief Eth/Cmpl Ofcr & SVP, ERMApr 12Sale125.154,735592,58522,085Apr 16 02:36 PM
Shah Aarti S.SVP & CIOApr 05Sale125.851,800226,53018,425Apr 08 02:54 PM
LILLY ENDOWMENT INC10% OwnerMar 26Sale131.41205,00026,938,688116,810,304Mar 27 02:57 PM
Zakrowski Donald AChief Accounting OfficerMar 22Sale128.501,000128,5004,595Mar 22 03:16 PM
Fry Stephen FSVP, HR & DiversityMar 12Sale123.1614,8471,828,557109,663Mar 13 12:47 PM
LILLY ENDOWMENT INC10% OwnerMar 01Sale128.43210,00026,971,215117,015,304Mar 04 02:13 PM
Zakrowski Donald AChief Accounting OfficerMar 01Sale127.011,000127,0105,595Mar 05 03:51 PM
LILLY ENDOWMENT INC10% OwnerFeb 28Sale126.73200,00025,345,017117,225,304Mar 01 01:25 PM
LILLY ENDOWMENT INC10% OwnerFeb 22Sale124.19195,00024,217,635117,425,304Feb 25 04:06 PM
LILLY ENDOWMENT INC10% OwnerFeb 19Sale122.48205,00025,108,513117,620,304Feb 20 01:35 PM
Norton JohnaSenior VP, Global QualityFeb 16Option Exercise0.0048082Feb 20 03:52 PM
Conterno Enrique ASVP&Pres, LillyDiab & LillyUSAFeb 15Sale121.0025,0003,025,000132,962Feb 20 03:37 PM
O'Neill MylesSVP & Pres., Mfg. OperationsFeb 01Option Exercise0.003,221054,175Feb 06 08:10 PM
Zulueta Alfonso GSVP & President, Lilly Int'lFeb 01Option Exercise0.009,722050,946Feb 05 07:09 PM
Ricks David APresident & CEOFeb 01Option Exercise0.0012,2220131,708Feb 05 07:04 PM
Harrington Michael JSenior VP and General CounselFeb 01Option Exercise0.0012,7780102,548Feb 05 06:59 PM
Fry Stephen FSVP, HR & DiversityFeb 01Option Exercise0.008,8890109,100Feb 05 06:55 PM
Conterno Enrique ASVP&Pres, LillyDiab & LillyUSAFeb 01Option Exercise0.0012,2220136,756Feb 05 06:49 PM
Barnes Melissa SChief Eth/Cmpl Ofcr & SVP, ERMFeb 01Option Exercise0.003,333020,901Feb 05 06:43 PM
LILLY ENDOWMENT INC10% OwnerJan 17Sale118.33136,57716,161,281117,825,304Jan 18 01:14 PM
LILLY ENDOWMENT INC10% OwnerJan 16Sale117.871,657195,315117,961,881Jan 17 01:15 PM
LILLY ENDOWMENT INC10% OwnerJan 15Sale117.7451,7666,095,136117,963,538Jan 16 02:36 PM
O'Neill MylesSVP & Pres., Mfg. OperationsDec 10Sale112.9225,0002,822,95950,954Dec 12 03:15 PM
LILLY ENDOWMENT INC10% OwnerDec 04Sale119.0015,5001,844,536118,015,304Dec 06 03:43 PM
White Anne E.SVP & Pres-Lilly OncologyDec 02Option Exercise0.007,500017,103Dec 04 03:14 PM
LILLY ENDOWMENT INC10% OwnerNov 29Sale117.42185,00021,722,429118,030,804Nov 30 11:52 AM
LILLY ENDOWMENT INC10% OwnerNov 28Sale115.57190,00021,957,939118,215,804Nov 29 10:55 AM
LILLY ENDOWMENT INC10% OwnerNov 19Sale115.31195,00022,485,572118,405,804Nov 20 02:40 PM
LILLY ENDOWMENT INC10% OwnerNov 16Sale113.74200,00022,747,000118,600,804Nov 19 01:53 PM
LILLY ENDOWMENT INC10% OwnerNov 13Sale113.412,460278,979118,800,804Nov 14 10:44 AM
LILLY ENDOWMENT INC10% OwnerNov 12Sale113.48202,54022,984,877118,803,264Nov 13 10:51 AM
LILLY ELI & CO10% OwnerNov 06Sale14.00700,0009,800,0003,148,647Nov 08 11:34 AM
Norton JohnaSenior VP, Global QualityNov 03Option Exercise0.003,133019,225Nov 06 01:25 PM
LILLY ENDOWMENT INC10% OwnerOct 17Sale113.25174,69619,783,623119,005,804Oct 18 02:26 PM
LILLY ENDOWMENT INC10% OwnerOct 09Sale115.9110,6721,237,013119,180,500Oct 10 01:17 PM
LILLY ENDOWMENT INC10% OwnerOct 08Sale115.9114,6321,696,039119,191,172Oct 09 01:14 PM
LILLY ENDOWMENT INC10% OwnerOct 04Sale112.67116,03813,073,950119,205,804Oct 05 02:47 PM
Zulueta Alfonso GSVP & President, Lilly Int'lOct 04Sale114.647,000802,48045,224Oct 05 02:08 PM
LILLY ENDOWMENT INC10% OwnerOct 03Sale109.0178,9628,607,253119,321,842Oct 04 02:29 PM
LILLY ENDOWMENT INC10% OwnerSep 28Sale107.31107,55311,541,082119,400,804Oct 01 11:53 AM
LILLY ENDOWMENT INC10% OwnerSep 27Sale107.0092,4479,891,644119,508,357Sep 28 10:36 AM
LILLY ENDOWMENT INC10% OwnerSep 26Sale106.63134,41014,332,373119,600,804Sep 27 12:26 PM
LILLY ENDOWMENT INC10% OwnerSep 25Sale106.4155,5905,915,165119,735,214Sep 26 01:49 PM
LILLY ELI & CO10% OwnerSep 24Sale16.362,02733,1623,848,647Sep 26 02:50 PM
LILLY ELI & CO10% OwnerSep 18Sale14.566,870100,0273,850,674Sep 20 04:50 PM
Zulueta Alfonso GSVP & President, Lilly Int'lSep 18Sale107.003,000321,00052,224Sep 19 05:47 PM
Zulueta Alfonso GSVP & President, Lilly Int'lSep 17Sale105.613,000316,83055,224Sep 19 05:47 PM
LILLY ELI & CO10% OwnerSep 17Sale14.586,865100,0923,857,544Sep 18 07:30 PM
LILLY ELI & CO10% OwnerSep 14Sale14.589,009131,3513,864,409Sep 18 07:30 PM
LILLY ELI & CO10% OwnerSep 13Sale14.3220,900299,2883,873,418Sep 14 03:34 PM
LILLY ELI & CO10% OwnerSep 12Sale14.8310,059149,1753,894,318Sep 14 03:34 PM
LILLY ELI & CO10% OwnerSep 11Sale14.8711,277167,6893,904,377Sep 12 04:39 PM
LILLY ELI & CO10% OwnerSep 10Sale14.444,50064,9803,915,654Sep 12 04:39 PM
LILLY ENDOWMENT INC10% OwnerSep 07Sale106.76180,00019,217,055119,790,804Sep 10 12:44 PM
Zakrowski Donald AChief Accounting OfficerSep 04Sale105.5760063,3423,530Sep 04 04:50 PM
LILLY ELI & CO10% OwnerAug 31Sale14.267009,9823,920,154Sep 04 03:38 PM
LILLY ENDOWMENT INC10% OwnerAug 30Sale105.42190,00020,030,370119,970,804Aug 31 09:07 AM
LILLY ELI & CO10% OwnerAug 30Sale14.353,44049,3643,920,854Aug 31 12:40 PM
LILLY ELI & CO10% OwnerAug 29Sale14.262,31232,9693,924,294Aug 31 12:40 PM
LILLY ENDOWMENT INC10% OwnerAug 20Sale105.89195,00020,647,575120,160,804Aug 21 02:12 PM
LILLY ENDOWMENT INC10% OwnerAug 16Sale104.50200,00020,899,800120,355,804Aug 17 03:08 PM
LILLY ENDOWMENT INC10% OwnerAug 15Sale103.23151,79315,669,440120,555,804Aug 16 02:52 PM
LILLY ELI & CO10% OwnerAug 14Sale14.283,00042,8403,926,606Aug 16 03:34 PM
LILLY ELI & CO10% OwnerAug 13Sale14.334,53164,9293,929,606Aug 14 05:04 PM
LILLY ENDOWMENT INC10% OwnerAug 10Sale103.063,587369,676120,707,597Aug 13 03:41 PM
LILLY ELI & CO10% OwnerAug 10Sale14.281,89827,1033,934,137Aug 14 05:04 PM
LILLY ENDOWMENT INC10% OwnerAug 07Sale103.2224,6202,541,326120,711,184Aug 08 01:28 PM
LILLY ENDOWMENT INC10% OwnerAug 06Sale102.15195,00019,918,860120,735,804Aug 07 11:46 AM
LILLY ELI & CO10% OwnerAug 03Sale13.551,65022,3583,936,035Aug 07 03:16 PM
LILLY ELI & CO10% OwnerAug 02Sale13.3119,400258,2143,937,685Aug 03 03:53 PM
LILLY ENDOWMENT INC10% OwnerAug 02Sale99.58190,00018,919,939120,930,804Aug 03 02:31 PM
LILLY ENDOWMENT INC10% OwnerJul 31Sale98.74205,00020,240,873121,120,804Aug 01 01:12 PM
TAI JACKSON PDirectorJul 26Buy95.222,168206,43753,228Jul 27 10:46 AM
LILLY ENDOWMENT INC10% OwnerJul 25Sale94.73190,00017,999,259121,325,804Jul 26 02:17 PM
LILLY ENDOWMENT INC10% OwnerJul 24Sale92.03185,00017,025,985121,515,804Jul 25 11:47 AM
LILLY ENDOWMENT INC10% OwnerJul 06Sale87.44180,00015,738,300121,700,804Jul 09 10:45 AM
Pusey Leigh AnnSVP, Corp. Affairs & Comm.Jul 05Option Exercise0.002,39402,394Jul 09 11:58 AM
LILLY ENDOWMENT INC10% OwnerJul 05Sale86.62170,00014,725,740121,880,804Jul 06 11:13 AM
LILLY ENDOWMENT INC10% OwnerJun 15Sale86.65180,00015,597,720122,050,804Jun 18 12:39 PM
Skovronsky DanielSVP, CSO, and Pres. LRLJun 14Buy86.2210,000862,20055,199Jun 14 04:08 PM
LILLY ENDOWMENT INC10% OwnerJun 14Sale86.31107,6989,295,414122,230,804Jun 15 11:00 AM
LILLY ENDOWMENT INC10% OwnerJun 13Sale86.2711,104957,953122,338,502Jun 14 11:58 AM
LILLY ENDOWMENT INC10% OwnerJun 11Sale86.3851,1984,422,637122,349,606Jun 12 02:46 PM
LILLY ENDOWMENT INC10% OwnerJun 04Sale85.13135,47811,532,565122,400,804Jun 05 11:20 AM
LILLY ENDOWMENT INC10% OwnerJun 01Sale85.3139,5223,371,661122,536,282Jun 04 02:25 PM
Conterno Enrique ASVP&Pres, LillyDiab & LillyUSAMay 31Sale85.0025,0002,125,000124,534Jun 01 04:22 PM
LILLY ENDOWMENT INC10% OwnerMay 30Sale83.85180,00015,092,640122,575,804May 31 01:18 PM
Shaw ChristiSVP and Pres., Lilly Bio-MedsMay 29Sale82.108,426691,7750May 31 01:05 PM